VCAM1-VLA4 inhibitors (Kaken)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVCAM1-VLA4 inhibitors (Kaken)
Drug Alias Namecell adhesion inhibitors (Kaken)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular cell adhesion molecule 1 inhibitors
TargetsVascular cell adhesion molecule 1
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A